Biomarkers study in atypical dementia: proof of a diagnostic work-up

[1] McKhann GM(2011)The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimers Dement 7 263-269

[2] Knopman DS(2001)Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of neurology Neurology 56 1143-1153

[3] Li P(2016)Correlated patterns of neuropsychological and behavioral symptoms in frontal variant of Alzheimer disease and behavioral variant frontotemporal dementia: a comparative case study Neurol Sci 37 797-803

[4] Zhou YY(2014)Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria Lancet Neurol 13 614-629

[5] Lu D(2016)Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease Neurol Sci 37 663-672

[6] Wang Y(2017)Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers Lancet Neurol 16 661-676

[7] Zhang HH(2015)The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey Alzheimers Dement 11 195-206

[8] Dubois B(2015)Amyloid biomarkers in Alzheimer’s disease Trends Pharmacol Sci 36 297-309

[9] Feldman HH(2015)Critical comparison of different biomarkers for Alzheimer’s disease in a clinical setting J Alzheimers Dis 48 425-432

[10] Jacova C(2017)Suspected non Alzheimer’s pathology—is it non-Alzheimer’s or non-amyloid? Ageing Res Rev 36 20-31

[1] McKhann GM(2011)The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimers Dement 7 263-269

[2] Knopman DS(2001)Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of neurology Neurology 56 1143-1153

[3] Li P(2016)Correlated patterns of neuropsychological and behavioral symptoms in frontal variant of Alzheimer disease and behavioral variant frontotemporal dementia: a comparative case study Neurol Sci 37 797-803

[4] Zhou YY(2014)Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria Lancet Neurol 13 614-629

[5] Lu D(2016)Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease Neurol Sci 37 663-672

[6] Wang Y(2017)Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers Lancet Neurol 16 661-676

[7] Zhang HH(2015)The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey Alzheimers Dement 11 195-206

[8] Dubois B(2015)Amyloid biomarkers in Alzheimer’s disease Trends Pharmacol Sci 36 297-309

[9] Feldman HH(2015)Critical comparison of different biomarkers for Alzheimer’s disease in a clinical setting J Alzheimers Dis 48 425-432

[10] Jacova C(2017)Suspected non Alzheimer’s pathology—is it non-Alzheimer’s or non-amyloid? Ageing Res Rev 36 20-31